|
1
|
Tasal A, Erturk M, Uyarel H, Karakurt H,
Bacaksiz A, Vatankulu MA, Turfan M, Sonmez O, Erdogan E and Ergelen
M: Utility of the neutrophil to lymphocyte ratio for predicting
in-hospital mortality after levosimendan infusion in patients with
acute decompensated heart failure. J Cardiol. 63:418–423. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan W, Li RJ, Jia Q, Mu Y, Liu CL and He
KL: Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain
natriuretic peptide as a prognostic marker of adverse events in
elderly patients with chronic heart failure. J Geriatr Cardiol.
14:127–134. 2017.PubMed/NCBI
|
|
3
|
Ostrowska M, Ostrowski A, Łuczak M,
Jaguszewski M, Adamski P, Bellwon J, Rynkiewicz A and Gruchała M:
Basic laboratory parameters as predictors of in-hospital death in
patients with acute decompensated heart failure: Data from a large
single-centre cohort. Kardiol Pol. 75:157–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ho KK, Anderson KM, Kannel WB, Grossman W
and Levy D: Survival after the onset of congestive heart failure in
Framingham Heart Study subjects. Circulation. 88:107–115. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Afari ME and Bhat T: Neutrophil to
lymphocyte ratio (NLR) and cardiovascular diseases: An update.
Expert Rev Cardiovasc Ther. 14:573–577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhat T, Teli S, Rijal J, Bhat H, Raza M,
Khoueiry G, Meghani M, Akhtar M and Costantino T: Neutrophil to
lymphocyte ratio and cardiovascular diseases: A review. Expert Rev
Cardiovasc Ther. 11:55–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wasilewski J, Pyka Ł, Hawranek M, Osadnik
T, Kurek A, Skrzypek M, Niedziela J, Desperak P, Kułaczkowska Z,
Brzezina M, et al: Prognostic value of neutrophil-to-lymphocyte
ratio in predicting long-term mortality in patients with ischemic
and nonischemic heart failure. Pol Arch Med Wewn. 126:166–173.
2016.PubMed/NCBI
|
|
8
|
Uthamalingam S, Patvardhan EA, Subramanian
S, Ahmed W, Martin W, Daley M and Capodilupo R: Utility of the
neutrophil to lymphocyte ratio in predicting long-term outcomes in
acute decompensated heart failure. Am J Cardiol. 107:433–438. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benites-Zapata VA, Hernandez AV, Nagarajan
V, Cauthen CA, Starling RC and Tang WH: Usefulness of
neutrophil-to-lymphocyte ratio in risk stratification of patients
with advanced heart failure. Am J Cardiol. 115:57–61. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan W, Liu C, Li R, Mu Y, Jia Q and He K:
Usefulness of the neutrophil-to-lymphocyte ratio in predicting
adverse events in elderly patients with chronic heart failure. Int
Heart J. 57:615–621. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du
P, Wang Q and Yang W: Prognostic role of pretreatment blood
neutrophil-to-lymphocyte ratio in advanced cancer survivors: A
systematic review and meta-analysis of 66 cohort studies. Cancer
Treat Rev. 58:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shannon CP, Balshaw R, Chen V, Hollander
Z, Toma M, McManus BM, Fitzgerald JM, Sin DD, Ng RT and Tebbutt SJ:
A novel approach to identifying marker genes and estimating the
cellular composition of whole blood from gene expression profiles.
bioRxiv. 2:387942016.
|
|
13
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Troyanskaya O, Cantor M, Sherlock G, Brown
P, Hastie T, Tibshirani R, Botstein D and Altman RB: Missing value
estimation methods for DNA microarrays. Bioinformatics. 17:520–525.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:(Database Issue). D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gene Ontology Consortium, . The Gene
Ontology (GO) project in 2006. Nucleic Acids Res. 34:(Database
Issue). D322–D326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff Finder: A
comprehensive and straightforward Web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weber C, Zernecke A and Libby P: The
multifaceted contributions of leukocyte subsets to atherosclerosis:
Lessons from mouse models. Nat Rev Immunol. 8:802–815. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Azab B, Zaher M, Weiserbs KF, Torbey E,
Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D
and Lafferty J: Usefulness of neutrophil to lymphocyte ratio in
predicting short- and long-term mortality after non-ST-elevation
myocardial infarction. Am J Cardiol. 106:470–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McBride BF, Yang T, Liu K, Urban TJ,
Giacomini KM, Kim RB and Roden DM: The organic cation transporter,
OCTN1, expressed in the human heart, potentiates antagonism of the
HERG potassium channel. J Cardiovasc Pharmacol. 54:63–71. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taubert D, Lazar A, Grimberg G, Jung N,
Rubbert A, Delank KS, Perniok A, Erdmann E and Schömig E:
Association of rheumatoid arthritis with ergothioneine levels in
red blood cells: A case control study. J Rheumatol. 33:2139–2145.
2006.PubMed/NCBI
|
|
25
|
Long F, Wang L, Yang L, Ji Z and Hu Y:
Screening hub genes in coronary artery disease based on integrated
analysis. Cardiol J. Oct 5–2017.(Epub ahead of print). PubMed/NCBI
|
|
26
|
Stoynev N, Dimova I, Rukova B, Hadjidekova
S, Nikolova D, Toncheva D and Tankova T: Gene expression in
peripheral blood of patients with hypertension and patients with
type 2 diabetes. J Cardiovasc Med (Hagerstown). 15:702–709. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mehra MR, Uber PA and Benitez RM:
Gene-based bio-signature patterns and cardiac allograft rejection.
Heart Fail Clin. 6:87–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen X, Chen X, Xu Y, Yang W, Wu N, Ye H,
Yang JY, Hong Q, Xin Y, Yang MQ, et al: Association of six CpG-SNPs
in the inflammation-related genes with coronary heart disease. Hum
Genomics. 10 Suppl 2:S212016. View Article : Google Scholar
|
|
29
|
Park HJ, Noh JH, Eun JW, Koh YS, Seo SM,
Park WS, Lee JY, Chang K, Seung KB, Kim PJ and Nam SW: Assessment
and diagnostic relevance of novel serum biomarkers for early
decision of ST-elevation myocardial infarction. Oncotarget.
6:12970–12983. 2015.PubMed/NCBI
|
|
30
|
Lu Y and Chen X, Yin Z, Zhu S, Wu D and
Chen X: Screening for potential serum biomarkers in rat mesangial
proliferative nephritis. Proteomics. 16:1015–1022. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jansen PA, Kamsteeg M, Rodijk-Olthuis D,
van Vlijmen-Willems IM, de Jongh GJ, Bergers M, Tjabringa GS,
Zeeuwen PL and Schalkwijk J: Expression of the vanin gene family in
normal and inflamed human skin: Induction by proinflammatory
cytokines. J Invest Dermatol. 129:2167–2174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
O'Meara E, Clayton T, McEntegart MB,
McMurray JJ, Piña IL, Granger CB, Ostergren J, Michelson EL,
Solomon SD, Pocock S, et al: Sex differences in clinical
characteristics and prognosis in a broad spectrum of patients with
heart failure: Results of the Candesartan in Heart failure:
Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation. 115:3111–3120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cakici M, Cetin M, Doğan A, Oylumlu M,
Aktürk E, Polat M, Suner A and Abuş S: Neutrophil to lymphocyte
ratio predicts poor functional capacity in patients with heart
failure. Turk Kardiyol Dern Ars. 42:612–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
